Sort
35,931 grants matching “parkinsons”
Studies in Dementia and Neurodegenerative Diseases
$770,343Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2012 · AG
The neural bases of placebo effects and their relation to regulatory processes
$769,982Tor Dessart Wager · Dartmouth College · R01 · FY2019 · MH
Metabolic Mechanisms in Locus Coeruleus Neuron Vulnerability in Neurodegenerative Disease
$769,665Eric M Morrow · Brown University · R01 · FY2025 · AG
Chronic Psychiatric Disorders: Linking Genes to Functional Disability
$769,658Ann E Pulver · Johns Hopkins University · R01 · FY2007 · MH
An Automated Platform for High-throughput Network Electrophysiology
$769,587James Ross · Axion Biosystems, Llc · R44 · FY2013 · NS
Targeting mediators of oxidative stress to limit hyperinflammatory cell death modalities during Mycobacterium tuberculosis infection
$769,168Robert Owen Watson · Vanderbilt University Medical Center · R01 · FY2025 · AI
Alpha-synuclein aggregate induced synapse loss is a pathological event contributing to Lewy body dementias
$768,806Laura Volpicelli-Daley · University Of Alabama At Birmingham · R56 · FY2020 · NS
Defining TBK1-associated autophagy networks in neurons
$768,349Daniel Adam Mordes · University Of California, San Francisco · R01 · FY2025 · AG
CORE--RELIGIOUS ORDERS STUDY
$768,297David A Bennett · Rush University Medical Center · P30 · FY2009 · AG
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells
$768,246Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R37 · FY2012 · HD
Lewy Body Dementia Biomarkers
$768,184Kirk A Frey · University Of Michigan At Ann Arbor · U01 · FY2022 · NS
Lewy Body Dementia Biomarkers
$768,184Kirk A Frey · University Of Michigan At Ann Arbor · U01 · FY2021 · NS
Mechanisms of Prion Protein Toxicity
$768,128David A Harris · Boston University Medical Campus · R01 · FY2025 · NS
Mechanisms of swallowing dysfunction and rescue in a translational rat model of Alzheimer's disease
$768,119Nadine Pattakos Connor · University Of Wisconsin-Madison · R01 · FY2023 · AG
Glutamate receptors and human neurological disease
$768,093Stephen F. Traynelis · Emory University · R35 · FY2023 · NS
Glutamate receptors and human neurological disease
$768,092Stephen F. Traynelis · Emory University · R35 · FY2022 · NS
The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease
$768,085Kathleen Lombard Poston · Stanford University · R01 · FY2020 · NS
HOME: Monitoring Balance and Gait with the Home Objective Mobility Exam
$767,705Mahmoud El-Gohary · Apdm, Inc. · R44 · FY2017 · AG
An examination of psychomotor disturbance in current and remitted MDD: An RDoC Study
$767,642Stewart Aaron Shankman · Northwestern University At Chicago · R01 · FY2019 · MH
Functional Organization of the Cerebral Cortex and Basal Ganglia
$767,594Charles R Gerfen · National Institute Of Mental Health · ZIA · FY2022 · MH
2007 NIH Director's Pioneer Award Program (DP1)
$767,500Rustem F Ismagilov · University Of Chicago · DP1 · FY2009 · OD
2007 NIH Director's Pioneer Award Program (DP1)
$767,500Rustem F Ismagilov · University Of Chicago · DP1 · FY2008 · OD
2007 NIH Director's Pioneer Award Program (DP1)
$767,500Rustem F Ismagilov · University Of Chicago · DP1 · FY2007 · OD
Neuroprotective Immunity and HIV Dementia
$767,498Howard Eliot Gendelman · University Of Nebraska Medical Center · R01 · FY2024 · NS
Neuroprotective Immunity and HIV Dementia
$767,498Howard Eliot Gendelman · University Of Nebraska Medical Center · R01 · FY2023 · NS